ZVRA EPS Estimates
Zevra Therapeutics, Inc.
$10.23
-$0.16(-1.54%)
56
Overall
80
Value
40
Tech
50
Quality
Market Cap
$617.00M
Volume
752.14K
52W Range
$8.01 - $15.04
Target Price
$25.25
ZVRA EPS estimates: the consensus estimate for Zevra Therapeutics, Inc.'s current fiscal year is $0.72 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ZVRA EPS Estimates
- EPS estimate, current quarter
- $0.14
- EPS estimate, next quarter
- $0.16
- EPS estimate, current year
- $0.72
- EPS estimate, next year
- $0.84
- EPS growth, 3-year
- +46.85%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.40 |
| 2024 | $-2.28 |
| 2023 | $-1.30 |
| 2022 | $-1.20 |
| 2021 | $-2.11 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZVRA | $10.23 | -1.5% | 752.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zevra Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW